You are here: University of Sydney / Sydney Medical School / Our people / Associate Professor Simone Strasser 

Associate Professor Simone Strasser

Clinical Associate Professor
Medicine, Central Clinical School
A W Morrow Gastroenterology and Liver Centre

Telephone +61 2 9515 7606
Fax +61 2 9515 5182

Map

Keywords

Liver Cancer; Transplantation; Hepatology; Hepatitis

Back to Top

Clinical Specialty

Gastroenterology and Hepatology

Back to Top

Selected grants

2008

  • Epidemiology, prevention and management of liver cancer in NSW: Towards a strategic research partnership; Strasser S, George J, McCaughan G, Dore G, Liddle C, Strasser S; Cancer Council New South Wales/Strategic Research Partnership (STREP) Grants.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Hockenbery, D., Strasser, S., McDonald, G. (2016). Gastrointestinal and Hepatic Complications. In S J Forman, R S Negrin, J H Antin, F R Appelbaum (Eds.), Thomas' Hematopoietic Cell Transplantation, (pp. 1140-1155). Chichester: John Wiley & Sons. [More Information]
  • Greenup, A., Strasser, S., Duffy, S. (2014). Primary care management of chronic hepatitis C. In M Burke, T Cabrie, B Cowie, G Dore, S Duffy, G Matthews, R McCoy, et al (Eds.), HIV, Viral Hepatitis and STIs: A guide for Primary Care (2014 Edition), (pp. 125-134). Sydney: ASHM - Australasian Society for HIV Medicine.
  • James, M., Strasser, S. (2009). Management of advanced liver disease. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 330-351). East Hawthorn, Victoria: IP Communications.

Journals

  • Pattullo, V., Pattullo, G., Strasser, S. (2018). Adverse effects of modified release oxycodone/naloxone in patients with moderate to severe liver impairment. Medical Journal of Australia, 209(6), 279-280. [More Information]
  • Krag, A., Schuchmann, M., Sodatonou, H., Pilot, J., Whitehouse, J., Strasser, S., Hudson, M. (2018). Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-[alpha] (PROSPER): an observational study among 550 patients. Hepatology, Medicine and Policy, 3, 1-8. [More Information]
  • Agarwal, N., Davis, R., Gracey, D., Wong, G., Kable, K., Wong, J., Nankivell, B., Strasser, S., Wyburn, K. (2018). Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy. Transplantation, 102(3), e121-e122. [More Information]
  • Laube, R., Wang, H., Park, L., Heyman, J., Vidot, H., Majumdar, A., Strasser, S., McCaughan, G., Liu, K. (2018). Frailty in advanced liver disease. Liver International, 38(12), 1980-1994. [More Information]
  • Baars, J., Strasser, S., Kaffes, A., Saxena, P. (2018). Gastrointestinal: Knot the intent. Journal of Gastroenterology and Hepatology, 33(8), 1431. [More Information]
  • Puoti, M., Foster, G., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T., Lee, S., Marinho, R., Dufour, J., Strasser, S., et al (2018). High SVR12 with 8-week and 12-week Glecaprevir/Pibrentasvir: Integrated Analysis of HCV Genotype 1-6 Patients Without Cirrhosis. Journal of Hepatology, 69(2), 293-300. [More Information]
  • Reddy, K., Pol, S., Thuluvath, P., Kumada, H., Toyota, J., Chayama, K., Levin, J., Lawitz, E., Gadano, A., Ghesquiere, W., Strasser, S., et al (2018). Long-Term Follow-Up of Clinical Trial Patients Treated for Chronic HCV Infection with Daclatasvir-Based Regimens. Liver International, 38(5), 821-833. [More Information]
  • Vidot, H., Cvejic, E., Carey, S., Strasser, S., McCaughan, G., Allman-Farinelli, M., Shackel, N. (2018). Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics, 48(7), 704-712. [More Information]
  • Kong, Y., Strasser, S., McCaughan, G., Crawford, M., Verran, D. (2018). Sclerosing peritonitis post liver transplantation: a rare condition where surgery is an important treatment option. ANZ Journal of Surgery, 88(5), E424-E428. [More Information]
  • McCaughan, G., Thwaites, P., Roberts, S., Strasser, S., Mitchell, J., Morales, B., Mason, S., Gow, P., Wigg, A., George, J., et al (2018). Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15). Alimentary Pharmacology and Therapeutics, 47(3), 401-411. [More Information]
  • Zeuzem, S., Serfaty, L., Vierling, J., Cheng, W., George, J., Sperl, J., Strasser, S., Kumada, H., Hwang, P., Robertson, M., et al (2018). The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection. Journal of Gastroenterology, 53(5), 679-688. [More Information]
  • Wong, M., McCaughan, G., Strasser, S. (2017). An update on the pathophysiology and management of polycystic liver disease. Expert Review of Gastroenterology and Hepatology, 11(6), 569-581. [More Information]
  • Morris, P., Laurence, J., Yeo, D., Crawford, M., Strasser, S., McCaughan, G., Sandroussi, C. (2017). Can response to locoregional therapy help predict longterm survival after liver transplantation for hepatocellular carcinoma? A systematic review. Liver Transplantation, 23(3), 375-385. [More Information]
  • Vinaixa, C., Strasser, S., Berenguer, M. (2017). Disease reversibility in patients with post-hepatitis c cirrhosis: Is the point of no return the same before and after liver transplantation? A review. Transplantation, 101(5), 916-923. [More Information]
  • Hezode, C., Colombo, M., Bourliere, M., Spengler, U., Ben-Ari, Z., Strasser, S., Lee, W., Morgan, L., Qiu, J., Hwang, P., et al (2017). Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study. Hepatology, 66(3), 736-745. [More Information]
  • Liu, K., Wang, R., Kariyawasam, V., Wells, M., Strasser, S., McCaughan, G., Corte, C., Leong, R. (2017). Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver International, 37(3), 442-448. [More Information]
  • Lum, L., Chen, F., Jackett, L., Strasser, S., Davis, R. (2017). Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor. Transplantation Direct, 3(7), 1-3. [More Information]
  • Lim, L., Thompson, A., Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., et al (2017). Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy. Liver International, 37(6), 827-835. [More Information]
  • Liu, K., Strasser, S., Koorey, D., Leong, R., Solomon, M., McCaughan, G. (2017). Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Review of Gastroenterology and Hepatology, 11(10), 949-960. [More Information]
  • Terrault, N., McCaughan, G., Curry, M., Gane, E., Fagiuoli, S., Fung, J., Agarwal, K., Lilly, L., Strasser, S., Brown, K., et al (2017). International liver transplantation society consensus statement on hepatitis c management in liver transplant candidates. Transplantation, 101(5), 945-955. [More Information]
  • Terrault, N., Berenguer, M., Strasser, S., Gadano, A., Lilly, L., Samuel, D., Kwo, P., Agarwal, K., Curry, M., Fagiuoli, S., McCaughan, G., et al (2017). International liver transplantation society consensus statement on hepatitis c management in liver transplant recipients. Transplantation, 101(5), 956-967. [More Information]
  • Strasser, S. (2017). Longterm outcome of the liver graft: A clinician's perspectiverecurrent disease, the universal shifting. Liver Transplantation, 23, S64-S69. [More Information]
  • Strasser, S. (2017). Managing hepatitis C in general practice. Australian Prescriber, 40(2), 64-69. [More Information]
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease Chronic hepatitis B and C. Medicine Today, 18(2), 34-42.
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease: chronic hepatitis B and C. Medicine Today, 18(2), 34-42.
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease: nonalcoholic fatty liver disease and alcoholic liver disease. Medicine Today, 18(1), 28-35.
  • Mohsen, W., Rodov, M., Prakoso, E., Charlton, B., Bowen, D., Koorey, D., Shackel, N., McCaughan, G., Strasser, S. (2017). Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma. World Journal of Gastroenterology, 23(15), 2763-2770. [More Information]
  • Liu, K., Joshi, V., van Camp, L., Yang, Q., Baars, J., Strasser, S., McCaughan, G., Majumdar, A., Saxena, P., Kaffes, A. (2017). Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients. World Journal of Gastroenterology, 23(48), 8526-8532. [More Information]
  • Bourliere, M., Gordon, S., Flamm, S., Cooper, C., Ramji, A., Tong, M., Ravendhran, N., Vierling, J., Tran, T., Strasser, S., et al (2017). Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. New England Journal of Medicine, 376(22), 2134-2146. [More Information]
  • Nevens, F., Andreone, P., Mazzella, G., Strasser, S., Bowlus, C., Invernizzi, P., Drenth, J., Pockros, P., Regula, J., Beuers, U., et al (2016). A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. New England Journal of Medicine, 375(7), 631-643. [More Information]
  • Vidot, H., Teevan, K., Carey, S., Strasser, S., Shackel, N. (2016). A prospective audit of preprocedural fasting practices on a transplant ward: When fasting becomes starving. Journal of Clinical Nursing, 25(5-6), 829-835. [More Information]
  • Foster, G., Chayama, K., Chuang, W., Fainboim, H., Farkkila, M., Gadano, A., Gaeta, G., Hezode, C., Inada, Y., Strasser, S., et al (2016). A randomized, controlled study of peginterferon lambda-1a/ribavirin � daclatasvir for hepatitis C virus genotype 2 or 3. SpringerPlus, 5(1), 1-12. [More Information]
  • Najjar, Z., Gupta, L., Pritchard-Jones, J., Strasser, S., Levy, M., Liaw, S., Cowle, B. (2016). A survey of Sydney general practitioners' management of patients with chronic hepatitis B. Medical Journal of Australia, 204(2), 74.e1-74.e4. [More Information]
  • McCaughan, G., Crawford, M., Sandroussi, C., Koorey, D., Bowen, D., Shackel, N., Strasser, S. (2016). Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? Internal Medicine Journal, 46(4), 404-412. [More Information]
  • Marcellin, P., Ahn, S., Ma, X., Caruntu, F., Tak, W., Elkashab, M., Chuang, W., Lim, S., Tabak, F., Mehta, R., Strasser, S., et al (2016). Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B. Gastroenterology, 150(1), 134-144.e10. [More Information]
  • Pudipeddi, A., Liu, K., Watson, G., Davis, R., Strasser, S. (2016). Cryptococcal osteomyelitis of the skull in a liver transplant patient. Transplant Infectious Disease, 18(6), 954-956. [More Information]
  • Visvanathan, K., Dusheiko, G., Giles, M., Wong, M., Phung, N., Walker, S., Le, S., Lim, S., Strasser, S., et al (2016). Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut, 65(2), 340-350. [More Information]
  • Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]
  • Marcellin, P., Ahn, S., Chuang, W., Hui, A., Tabak, F., Mehta, R., Petersen, J., Lee, C., Ma, X., Strasser, S., et al (2016). Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Alimentary Pharmacology and Therapeutics, 44(9), 957-966. [More Information]
  • Lampertico, P., Chan, H., Janssen, H., Strasser, S., Schindler, R., Berg, T. (2016). Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients. Alimentary Pharmacology and Therapeutics, 44(1), 16-34. [More Information]
  • Doyle, A., Marsh, P., Gill, R., Rodov, M., Mohsen, W., Varma, P., Hong, T., Strasser, S., Bell, S., Ryan, M., et al (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology, 51(8), 979-985. [More Information]
  • Howell, J., Balderson, G., Hellard, M., Gow, P., Strasser, S., Stuart, K., Wigg, A., Jeffrey, G., Gane, E., Angus, P. (2016). The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. Journal of Gastroenterology and Hepatology, 31(2), 434-441. [More Information]
  • Rahman, W., Tu, T., Budzinska, M., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Warner, F., Bowden, D., Thomspon, A., Bowen, D., Strasser, S., Sharland, A., Yang, J., McCaughan, G., Shackel, N., et al (2015). Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of differentiation Antibody Microarrays. Transplantation, 99(9), e120-e126. [More Information]
  • Dore, G., Lawitz, E., Hezode, C., Shafran, S., Ramji, A., Tatum, H., Taliani, G., Tran, A., Strasser, S., George, J., et al (2015). Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection. Gastroenterology, 148(2), 355-366. [More Information]
  • Pritchard-Jones, J., Stevens, C., McCaughan, G., Strasser, S. (2015). Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community. Collegian, 22(2), 233-240. [More Information]
  • Lepida, A., Colombo, M., Fernandez, I., Abdurakhmanov, D., Abrao Ferreira, P., Strasser, S., Urbanek, P., Mangia, A., Calleja, F., Iraqi, W., et al (2015). Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. PloS One, 10(9), 1-15. [More Information]
  • Pulitano, C., Joseph, D., Sandroussi, C., Verran, D., Strasser, S., Shackel, N., McCaughan, G., Crawford, M. (2015). Hepatic Artery Stenosis After Liver Transplantation: Is Endovascular Treatment Always Necessary? Liver Transplantation, 21(2), 162-168. [More Information]
  • McCaughan, G., Sze, K., Strasser, S. (2015). Is there such a thing as protocol immunosuppression in liver transplantation? Expert Review of Gastroenterology and Hepatology, 9(1), 1-4. [More Information]
  • Pianko, S., Flamm, S., Shiffman, M., Kumar, S., Strasser, S., Dore, G., Mcnally, J., Brainard, D., Han, L., Doehle, B., et al (2015). Sofosbuvir plus velpatasvir combination therapy for treatment- Experienced patients with genotype 1 or 3 hepatitis c virus infection: A randomized trial. Annals of Internal Medicine, 163(11), 809-817. [More Information]
  • Kitzing, Y., Ng, B., Kitzing, B., Waugh, R., Kench, J., Strasser, S., McCormack, S. (2015). Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. Journal of Medical Imaging and Radiation Oncology, 59(6), 673-680. [More Information]
  • Nguyen, V., Tan, P., Greenup, A., Glass, A., Davison, S., Samarasinghe, D., Holdaway, S., Strasser, S., Chatterjee, U., Jackson, K., et al (2014). Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Alimentary Pharmacology and Therapeutics, 39(10), 1225-1234. [More Information]
  • Chinnaratha, M., Chelvaratnam, U., Stuart, K., Strasser, S., McCaughan, G., Gow, P., Adams, L., Wigg, A. (2014). Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders. Liver Transplantation, 20(7), 798-806. [More Information]
  • Strasser, S. (2014). Managing hepatitis B to prevent liver cancer: recent advances. Expert Review of Gastroenterology and Hepatology, 8(4), 409-415. [More Information]
  • Davison, S., Strasser, S. (2014). Ordering and interpreting hepatitis B serology. BMJ, 348, g2522. [More Information]
  • Colombo, M., Fernandez, I., Abdurakhmanov, D., Ferreira, P., Strasser, S., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C. Gut, 63(7), 1150-1158. [More Information]
  • Colombo, M., Strasser, S., Moreno, C., Abrao Ferreira, P., Urbanek, P., Fernandez, I., Abdurakmonov, D., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Sustained Virological Response with Telaprevir in 1078 Patients With Advanced Hepatitis C: The International Telaprevir Access Program. Journal of Hepatology, 61(5), 976-983. [More Information]
  • Roberts, D., Hall, M., Falkland, M., Strasser, S., Buckley, N. (2013). Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales. Medical Journal of Australia, 198(1), 43-47. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
  • Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
  • Strasser, S. (2013). Hepatocellular carcinoma: The most rapidly rising cause of cancer death in Australia. Medicine Today, 14(12), 55-57.
  • Silva, M., Strasser, S., Carrilho, F. (2013). Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma? Clinics, 68(4), 437-440. [More Information]
  • Silva, M., Sapisochin, G., Strasser, S., Hewa-Geeganage, S., Chen, J., Wigg, A., Jones, R., Saraiva, R., Kikuchi, L., Carrilho, F., et al (2013). Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. European Journal of Surgical Oncology, 39(4), 386-395. [More Information]
  • Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
  • Gracey, D., Snelling, P., McKenzie, P., Strasser, S. (2013). Tenofovir-associated Fanconi Syndrome in patients with chronic hepatitis B monoinfection. Antiviral Therapy, 18(7), 945-948. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]
  • Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
  • Strasser, S. (2012). Another achievement in organ transplantation in Australia - yet much still needs to be done. Medical Journal of Australia, 197(8), 429-430. [More Information]
  • Strasser, S. (2012). Drugs in Development for the Treatment of Chronic Hepatitis B. Current Hepatology Reports, 11(2), 111-118. [More Information]
  • Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]
  • Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
  • Strasser, S., Vidot, H. (2011). Nutritional considerations in end-stage liver disease. Journal of Gastroenterology and Hepatology, 26(9), 1346-1348. [More Information]
  • Gidding, H., Law, M., Amin, J., Macdonald, G., Sasadeusz, J., Jones, T., Strasser, S., George, J., Dore, G. (2011). Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia, 194(8), 398-402. [More Information]
  • Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
  • Nightingale, S., O'Loughlin, E., Dorney, S., Shun, A., Verran, D., Strasser, S., McCaughan, G., Jermyn, V., Van Asperen, P., Gaskin, K., Stormon, M. (2010). Isolated liver transplantation in children with cystic fibrosis - An Australian experience. Pediatric Transplantation, 14(6), 779-785. [More Information]
  • Mahady, S., Carlton, B., FitzGerald, P., Koorey, D., Perry, J., Waugh, R., McCaughan, G., Strasser, S. (2010). Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage? Journal of Gastroenterology and Hepatology, 25(7), 1299-1305. [More Information]
  • McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
  • Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Locarnini, S., Bowden, S., et al (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut, 60(2), 247-254. [More Information]
  • Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
  • Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C-Related Liver Failure Post-Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
  • Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]
  • Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
  • Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
  • Strasser, S. (2008). When should liver biopsy be performed after hematopoietic stem cell transplantation? Journal of Gastroenterology and Hepatology, 23(2), 167-169. [More Information]
  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
  • Chiong, M., Bennetts, B., Strasser, S., Wilcken, B. (2007). Fatal late-onset ornithine transcarbamylase deficiency after coronary artery bypass surgery. Medical Journal of Australia, 186(8), 418-419. [More Information]
  • Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]
  • Salmond, S., George, J., Strasser, S., Batey, R. (2006). Hep573 study of complementary medicine for chronic hepatitis C. Journal Of Clinical Virology, 36(Supplement 2), S134-S135.
  • Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
  • St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
  • Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
  • Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]
  • Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
  • McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine, 66(1), 8-12. [More Information]
  • Samuel, D., Riordan, S., Strasser, S., Kurtovic, J., Singh-Grewel, I., Koorey, D. (2004). Severe Autoimmune Hepatitis First Presenting In The Early Post Partum Period. Clinical Gastroenterology and Hepatology, 2(7), 622-624. [More Information]
  • Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505. [More Information]
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive Transfer of Nut Allergy After Liver Transplantation. Archives of Internal Medicine, 163(2), 237-239. [More Information]
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239. [More Information]
  • Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185. [More Information]
  • McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400. [More Information]

2018

  • Pattullo, V., Pattullo, G., Strasser, S. (2018). Adverse effects of modified release oxycodone/naloxone in patients with moderate to severe liver impairment. Medical Journal of Australia, 209(6), 279-280. [More Information]
  • Krag, A., Schuchmann, M., Sodatonou, H., Pilot, J., Whitehouse, J., Strasser, S., Hudson, M. (2018). Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-[alpha] (PROSPER): an observational study among 550 patients. Hepatology, Medicine and Policy, 3, 1-8. [More Information]
  • Agarwal, N., Davis, R., Gracey, D., Wong, G., Kable, K., Wong, J., Nankivell, B., Strasser, S., Wyburn, K. (2018). Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy. Transplantation, 102(3), e121-e122. [More Information]
  • Laube, R., Wang, H., Park, L., Heyman, J., Vidot, H., Majumdar, A., Strasser, S., McCaughan, G., Liu, K. (2018). Frailty in advanced liver disease. Liver International, 38(12), 1980-1994. [More Information]
  • Baars, J., Strasser, S., Kaffes, A., Saxena, P. (2018). Gastrointestinal: Knot the intent. Journal of Gastroenterology and Hepatology, 33(8), 1431. [More Information]
  • Puoti, M., Foster, G., Wang, S., Mutimer, D., Gane, E., Moreno, C., Chang, T., Lee, S., Marinho, R., Dufour, J., Strasser, S., et al (2018). High SVR12 with 8-week and 12-week Glecaprevir/Pibrentasvir: Integrated Analysis of HCV Genotype 1-6 Patients Without Cirrhosis. Journal of Hepatology, 69(2), 293-300. [More Information]
  • Reddy, K., Pol, S., Thuluvath, P., Kumada, H., Toyota, J., Chayama, K., Levin, J., Lawitz, E., Gadano, A., Ghesquiere, W., Strasser, S., et al (2018). Long-Term Follow-Up of Clinical Trial Patients Treated for Chronic HCV Infection with Daclatasvir-Based Regimens. Liver International, 38(5), 821-833. [More Information]
  • Vidot, H., Cvejic, E., Carey, S., Strasser, S., McCaughan, G., Allman-Farinelli, M., Shackel, N. (2018). Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics, 48(7), 704-712. [More Information]
  • Kong, Y., Strasser, S., McCaughan, G., Crawford, M., Verran, D. (2018). Sclerosing peritonitis post liver transplantation: a rare condition where surgery is an important treatment option. ANZ Journal of Surgery, 88(5), E424-E428. [More Information]
  • McCaughan, G., Thwaites, P., Roberts, S., Strasser, S., Mitchell, J., Morales, B., Mason, S., Gow, P., Wigg, A., George, J., et al (2018). Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15). Alimentary Pharmacology and Therapeutics, 47(3), 401-411. [More Information]
  • Zeuzem, S., Serfaty, L., Vierling, J., Cheng, W., George, J., Sperl, J., Strasser, S., Kumada, H., Hwang, P., Robertson, M., et al (2018). The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection. Journal of Gastroenterology, 53(5), 679-688. [More Information]

2017

  • Wong, M., McCaughan, G., Strasser, S. (2017). An update on the pathophysiology and management of polycystic liver disease. Expert Review of Gastroenterology and Hepatology, 11(6), 569-581. [More Information]
  • Morris, P., Laurence, J., Yeo, D., Crawford, M., Strasser, S., McCaughan, G., Sandroussi, C. (2017). Can response to locoregional therapy help predict longterm survival after liver transplantation for hepatocellular carcinoma? A systematic review. Liver Transplantation, 23(3), 375-385. [More Information]
  • Vinaixa, C., Strasser, S., Berenguer, M. (2017). Disease reversibility in patients with post-hepatitis c cirrhosis: Is the point of no return the same before and after liver transplantation? A review. Transplantation, 101(5), 916-923. [More Information]
  • Hezode, C., Colombo, M., Bourliere, M., Spengler, U., Ben-Ari, Z., Strasser, S., Lee, W., Morgan, L., Qiu, J., Hwang, P., et al (2017). Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study. Hepatology, 66(3), 736-745. [More Information]
  • Liu, K., Wang, R., Kariyawasam, V., Wells, M., Strasser, S., McCaughan, G., Corte, C., Leong, R. (2017). Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver International, 37(3), 442-448. [More Information]
  • Lum, L., Chen, F., Jackett, L., Strasser, S., Davis, R. (2017). Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor. Transplantation Direct, 3(7), 1-3. [More Information]
  • Lim, L., Thompson, A., Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., et al (2017). Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy. Liver International, 37(6), 827-835. [More Information]
  • Liu, K., Strasser, S., Koorey, D., Leong, R., Solomon, M., McCaughan, G. (2017). Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Review of Gastroenterology and Hepatology, 11(10), 949-960. [More Information]
  • Terrault, N., McCaughan, G., Curry, M., Gane, E., Fagiuoli, S., Fung, J., Agarwal, K., Lilly, L., Strasser, S., Brown, K., et al (2017). International liver transplantation society consensus statement on hepatitis c management in liver transplant candidates. Transplantation, 101(5), 945-955. [More Information]
  • Terrault, N., Berenguer, M., Strasser, S., Gadano, A., Lilly, L., Samuel, D., Kwo, P., Agarwal, K., Curry, M., Fagiuoli, S., McCaughan, G., et al (2017). International liver transplantation society consensus statement on hepatitis c management in liver transplant recipients. Transplantation, 101(5), 956-967. [More Information]
  • Strasser, S. (2017). Longterm outcome of the liver graft: A clinician's perspectiverecurrent disease, the universal shifting. Liver Transplantation, 23, S64-S69. [More Information]
  • Strasser, S. (2017). Managing hepatitis C in general practice. Australian Prescriber, 40(2), 64-69. [More Information]
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease Chronic hepatitis B and C. Medicine Today, 18(2), 34-42.
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease: chronic hepatitis B and C. Medicine Today, 18(2), 34-42.
  • Pattullo, V., Strasser, S. (2017). Managing the rising burden of chronic liver disease: nonalcoholic fatty liver disease and alcoholic liver disease. Medicine Today, 18(1), 28-35.
  • Mohsen, W., Rodov, M., Prakoso, E., Charlton, B., Bowen, D., Koorey, D., Shackel, N., McCaughan, G., Strasser, S. (2017). Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma. World Journal of Gastroenterology, 23(15), 2763-2770. [More Information]
  • Liu, K., Joshi, V., van Camp, L., Yang, Q., Baars, J., Strasser, S., McCaughan, G., Majumdar, A., Saxena, P., Kaffes, A. (2017). Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients. World Journal of Gastroenterology, 23(48), 8526-8532. [More Information]
  • Bourliere, M., Gordon, S., Flamm, S., Cooper, C., Ramji, A., Tong, M., Ravendhran, N., Vierling, J., Tran, T., Strasser, S., et al (2017). Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. New England Journal of Medicine, 376(22), 2134-2146. [More Information]

2016

  • Nevens, F., Andreone, P., Mazzella, G., Strasser, S., Bowlus, C., Invernizzi, P., Drenth, J., Pockros, P., Regula, J., Beuers, U., et al (2016). A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. New England Journal of Medicine, 375(7), 631-643. [More Information]
  • Vidot, H., Teevan, K., Carey, S., Strasser, S., Shackel, N. (2016). A prospective audit of preprocedural fasting practices on a transplant ward: When fasting becomes starving. Journal of Clinical Nursing, 25(5-6), 829-835. [More Information]
  • Foster, G., Chayama, K., Chuang, W., Fainboim, H., Farkkila, M., Gadano, A., Gaeta, G., Hezode, C., Inada, Y., Strasser, S., et al (2016). A randomized, controlled study of peginterferon lambda-1a/ribavirin � daclatasvir for hepatitis C virus genotype 2 or 3. SpringerPlus, 5(1), 1-12. [More Information]
  • Najjar, Z., Gupta, L., Pritchard-Jones, J., Strasser, S., Levy, M., Liaw, S., Cowle, B. (2016). A survey of Sydney general practitioners' management of patients with chronic hepatitis B. Medical Journal of Australia, 204(2), 74.e1-74.e4. [More Information]
  • McCaughan, G., Crawford, M., Sandroussi, C., Koorey, D., Bowen, D., Shackel, N., Strasser, S. (2016). Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? Internal Medicine Journal, 46(4), 404-412. [More Information]
  • Marcellin, P., Ahn, S., Ma, X., Caruntu, F., Tak, W., Elkashab, M., Chuang, W., Lim, S., Tabak, F., Mehta, R., Strasser, S., et al (2016). Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B. Gastroenterology, 150(1), 134-144.e10. [More Information]
  • Pudipeddi, A., Liu, K., Watson, G., Davis, R., Strasser, S. (2016). Cryptococcal osteomyelitis of the skull in a liver transplant patient. Transplant Infectious Disease, 18(6), 954-956. [More Information]
  • Hockenbery, D., Strasser, S., McDonald, G. (2016). Gastrointestinal and Hepatic Complications. In S J Forman, R S Negrin, J H Antin, F R Appelbaum (Eds.), Thomas' Hematopoietic Cell Transplantation, (pp. 1140-1155). Chichester: John Wiley & Sons. [More Information]
  • Visvanathan, K., Dusheiko, G., Giles, M., Wong, M., Phung, N., Walker, S., Le, S., Lim, S., Strasser, S., et al (2016). Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut, 65(2), 340-350. [More Information]
  • Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S., McCaughan, G., George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PloS One, 11(5), 1-12. [More Information]
  • Marcellin, P., Ahn, S., Chuang, W., Hui, A., Tabak, F., Mehta, R., Petersen, J., Lee, C., Ma, X., Strasser, S., et al (2016). Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Alimentary Pharmacology and Therapeutics, 44(9), 957-966. [More Information]
  • Lampertico, P., Chan, H., Janssen, H., Strasser, S., Schindler, R., Berg, T. (2016). Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients. Alimentary Pharmacology and Therapeutics, 44(1), 16-34. [More Information]
  • Doyle, A., Marsh, P., Gill, R., Rodov, M., Mohsen, W., Varma, P., Hong, T., Strasser, S., Bell, S., Ryan, M., et al (2016). Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study. Scandinavian Journal of Gastroenterology, 51(8), 979-985. [More Information]
  • Howell, J., Balderson, G., Hellard, M., Gow, P., Strasser, S., Stuart, K., Wigg, A., Jeffrey, G., Gane, E., Angus, P. (2016). The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. Journal of Gastroenterology and Hepatology, 31(2), 434-441. [More Information]

2015

  • Rahman, W., Tu, T., Budzinska, M., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Warner, F., Bowden, D., Thomspon, A., Bowen, D., Strasser, S., Sharland, A., Yang, J., McCaughan, G., Shackel, N., et al (2015). Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of differentiation Antibody Microarrays. Transplantation, 99(9), e120-e126. [More Information]
  • Dore, G., Lawitz, E., Hezode, C., Shafran, S., Ramji, A., Tatum, H., Taliani, G., Tran, A., Strasser, S., George, J., et al (2015). Daclatasvir plus Peginterferon and Ribavirin is Non-inferior to Peginterferon and Ribavirin Alone, and Reduces Duration of Treatment for HCV Genotype 2 or 3 Infection. Gastroenterology, 148(2), 355-366. [More Information]
  • Pritchard-Jones, J., Stevens, C., McCaughan, G., Strasser, S. (2015). Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community. Collegian, 22(2), 233-240. [More Information]
  • Lepida, A., Colombo, M., Fernandez, I., Abdurakhmanov, D., Abrao Ferreira, P., Strasser, S., Urbanek, P., Mangia, A., Calleja, F., Iraqi, W., et al (2015). Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis. PloS One, 10(9), 1-15. [More Information]
  • Pulitano, C., Joseph, D., Sandroussi, C., Verran, D., Strasser, S., Shackel, N., McCaughan, G., Crawford, M. (2015). Hepatic Artery Stenosis After Liver Transplantation: Is Endovascular Treatment Always Necessary? Liver Transplantation, 21(2), 162-168. [More Information]
  • McCaughan, G., Sze, K., Strasser, S. (2015). Is there such a thing as protocol immunosuppression in liver transplantation? Expert Review of Gastroenterology and Hepatology, 9(1), 1-4. [More Information]
  • Pianko, S., Flamm, S., Shiffman, M., Kumar, S., Strasser, S., Dore, G., Mcnally, J., Brainard, D., Han, L., Doehle, B., et al (2015). Sofosbuvir plus velpatasvir combination therapy for treatment- Experienced patients with genotype 1 or 3 hepatitis c virus infection: A randomized trial. Annals of Internal Medicine, 163(11), 809-817. [More Information]
  • Kitzing, Y., Ng, B., Kitzing, B., Waugh, R., Kench, J., Strasser, S., McCormack, S. (2015). Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population. Journal of Medical Imaging and Radiation Oncology, 59(6), 673-680. [More Information]

2014

  • Nguyen, V., Tan, P., Greenup, A., Glass, A., Davison, S., Samarasinghe, D., Holdaway, S., Strasser, S., Chatterjee, U., Jackson, K., et al (2014). Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Alimentary Pharmacology and Therapeutics, 39(10), 1225-1234. [More Information]
  • Chinnaratha, M., Chelvaratnam, U., Stuart, K., Strasser, S., McCaughan, G., Gow, P., Adams, L., Wigg, A. (2014). Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders. Liver Transplantation, 20(7), 798-806. [More Information]
  • Strasser, S. (2014). Managing hepatitis B to prevent liver cancer: recent advances. Expert Review of Gastroenterology and Hepatology, 8(4), 409-415. [More Information]
  • Davison, S., Strasser, S. (2014). Ordering and interpreting hepatitis B serology. BMJ, 348, g2522. [More Information]
  • Greenup, A., Strasser, S., Duffy, S. (2014). Primary care management of chronic hepatitis C. In M Burke, T Cabrie, B Cowie, G Dore, S Duffy, G Matthews, R McCoy, et al (Eds.), HIV, Viral Hepatitis and STIs: A guide for Primary Care (2014 Edition), (pp. 125-134). Sydney: ASHM - Australasian Society for HIV Medicine.
  • Colombo, M., Fernandez, I., Abdurakhmanov, D., Ferreira, P., Strasser, S., Urbanek, P., Moreno, C., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C. Gut, 63(7), 1150-1158. [More Information]
  • Colombo, M., Strasser, S., Moreno, C., Abrao Ferreira, P., Urbanek, P., Fernandez, I., Abdurakmonov, D., Streinu-Cercel, A., Verheyen, A., Iraqi, W., et al (2014). Sustained Virological Response with Telaprevir in 1078 Patients With Advanced Hepatitis C: The International Telaprevir Access Program. Journal of Hepatology, 61(5), 976-983. [More Information]

2013

  • Roberts, D., Hall, M., Falkland, M., Strasser, S., Buckley, N. (2013). Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales. Medical Journal of Australia, 198(1), 43-47. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Author reply: RE Terlipressin therapy for moderate to severe hyponatraemia in patients with liver failure. Internal Medicine Journal, 43(5), 607-607. [More Information]
  • Gane, E., Patterson, S., Strasser, S., McCaughan, G., Angus, P. (2013). Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Liver Transplantation, 19(3), 268-274. [More Information]
  • Strasser, S. (2013). Hepatocellular carcinoma: The most rapidly rising cause of cancer death in Australia. Medicine Today, 14(12), 55-57.
  • Silva, M., Strasser, S., Carrilho, F. (2013). Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma? Clinics, 68(4), 437-440. [More Information]
  • Silva, M., Sapisochin, G., Strasser, S., Hewa-Geeganage, S., Chen, J., Wigg, A., Jones, R., Saraiva, R., Kikuchi, L., Carrilho, F., et al (2013). Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. European Journal of Surgical Oncology, 39(4), 386-395. [More Information]
  • Saunderson, R., Garsia, R., Headley, A., McCaughan, G., O'Toole, S., Strasser, S. (2013). Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. Journal of Dermatological Case Reports, 7(3), 77-81. [More Information]
  • Gracey, D., Snelling, P., McKenzie, P., Strasser, S. (2013). Tenofovir-associated Fanconi Syndrome in patients with chronic hepatitis B monoinfection. Antiviral Therapy, 18(7), 945-948. [More Information]
  • Prakoso, E., Jones, C., Koorey, D., Strasser, S., Bowen, D., McCaughan, G., Shackel, N. (2013). Terlipressin Therapy for Moderate to Severe Hyponatremia in Patients with Liver Failure. Internal Medicine Journal, 43(3), 240-246. [More Information]

2012

  • Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012). Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International, 32(10), 1527-1534. [More Information]
  • Strasser, S. (2012). Another achievement in organ transplantation in Australia - yet much still needs to be done. Medical Journal of Australia, 197(8), 429-430. [More Information]
  • Strasser, S. (2012). Drugs in Development for the Treatment of Chronic Hepatitis B. Current Hepatology Reports, 11(2), 111-118. [More Information]
  • Graaf, E., Kench, J., Dilworth, P., Shackel, N., Strasser, S., Joseph, D., Pleass, H., Crawford, M., McCaughan, G., Verran, D. (2012). Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. Journal of Gastroenterology and Hepatology, 27(3), 540-546. [More Information]

2011

  • Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011). Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology, 54(6), 1998-2004. [More Information]
  • Strasser, S., Vidot, H. (2011). Nutritional considerations in end-stage liver disease. Journal of Gastroenterology and Hepatology, 26(9), 1346-1348. [More Information]
  • Gidding, H., Law, M., Amin, J., Macdonald, G., Sasadeusz, J., Jones, T., Strasser, S., George, J., Dore, G. (2011). Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia, 194(8), 398-402. [More Information]

2010

  • Prakoso, E., Verran, D., Dilworth, P., Kyd, G., Tang, P., Tse, C., Koorey, D., Strasser, S., Stormon, M., Shun, A., Allen, R., et al (2010). Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Internal Medicine Journal, 40(9), 619-625. [More Information]
  • Nightingale, S., O'Loughlin, E., Dorney, S., Shun, A., Verran, D., Strasser, S., McCaughan, G., Jermyn, V., Van Asperen, P., Gaskin, K., Stormon, M. (2010). Isolated liver transplantation in children with cystic fibrosis - An Australian experience. Pediatric Transplantation, 14(6), 779-785. [More Information]
  • Mahady, S., Carlton, B., FitzGerald, P., Koorey, D., Perry, J., Waugh, R., McCaughan, G., Strasser, S. (2010). Locoregional therapies for hepatocellular carcinoma: Which patients are most likely to gain a survival advantage? Journal of Gastroenterology and Hepatology, 25(7), 1299-1305. [More Information]
  • McCaughan, G., Shackel, N., Strasser, S., Dilworth, P., Tang, P. (2010). Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark. Liver Transplantation, 16(2), 130-137. [More Information]
  • Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Locarnini, S., Bowden, S., et al (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut, 60(2), 247-254. [More Information]

2009

  • Sandroussi, C., Crawford, M., Lockwood, D., Tang, P., Gallagher, J., Pleass, H., Strasser, S., Shackel, N., McCaughan, G., Verran, D. (2009). Donor and recipient selection leads to good patient and graft outcomes for right lobe split transplantation versus whole graft liver transplantation in adult recipients. Liver Transplantation, 15(11), 1586-1593. [More Information]
  • Shackel, N., Jamias, J., Rahman, W., Prakoso, E., Strasser, S., Koorey, D., Crawford, M., Verran, D., Gallagher, J., McCaughan, G. (2009). Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C-Related Liver Failure Post-Liver Transplantation. Liver Transplantation, 15(7), 709-718. [More Information]
  • James, M., Strasser, S. (2009). Management of advanced liver disease. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 330-351). East Hawthorn, Victoria: IP Communications.
  • Geenen, I., Sosef, M., Shun, A., Crawford, M., Gallagher, J., Strasser, S., Stormon, M., McCaughan, G., Verran, D. (2009). Usage and Outcomes of Deceased Donor Liver Allografts with Preprocurement Injury from Blunt Trauma. Liver Transplantation, 15(3), 321-325. [More Information]

2008

  • Angus, P., Patterson, S., Strasser, S., McCaughan, G., Gane, E. (2008). A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis. Hepatology, 48(5), 1460-1466. [More Information]
  • Alghamdi, H., Crawford, M., Gallagher, J., McCaughan, G., Strasser, S., Verran, D. (2008). Cadaveric liver transplant from older donors. Saudi Medical Journal, 29(4), 533-538. [More Information]
  • Strasser, S. (2008). When should liver biopsy be performed after hematopoietic stem cell transplantation? Journal of Gastroenterology and Hepatology, 23(2), 167-169. [More Information]

2007

  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • Labio, E., Del Rosario, D., Strasser, S., McCaughan, G., Crawford, B. (2007). Effect of Ascites on Bone Density Measurement in Cirrhosis. Journal of Clinical Densitometry: Assessment of Skeletal Health, 10(4), 391-394. [More Information]
  • Chiong, M., Bennetts, B., Strasser, S., Wilcken, B. (2007). Fatal late-onset ornithine transcarbamylase deficiency after coronary artery bypass surgery. Medical Journal of Australia, 186(8), 418-419. [More Information]
  • Perry, J., Charlton, B., Koorey, D., Waugh, R., Gallagher, P., Crawford, M., Verran, D., McCaughan, G., Strasser, S. (2007). Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver International, 27(9), 1240-1248. [More Information]

2006

  • Salmond, S., George, J., Strasser, S., Batey, R. (2006). Hep573 study of complementary medicine for chronic hepatitis C. Journal Of Clinical Virology, 36(Supplement 2), S134-S135.
  • Loss, M., Ng, W., Karim, R., Strasser, S., Koorey, D., Gallagher, P., Verran, D., McCaughan, G. (2006). Hereditary lysozyme amyloidosis: Spontaneous hepatic rupture (15 years apart) in mother and daughter. Role of emeregency liver transplantation. Liver Transplantation, 12(7), 1152-1155. [More Information]
  • St George, A., Johnston, A., Bauman, A., Iverson, D., Tapsell, L., McCaughan, G., Strasser, S., McGrath, L., Green, J., Farrell, G., George, J. (2006). Lifestyle intervention in early liver disease: metabolic changes at 3 months. Journal of Gastroenterology and Hepatology, 21(Suppl. 4), A315.
  • Prakoso, E., Strasser, S., Koorey, D., Verran, D., McCaughan, G. (2006). Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation, 20(3), 369-373. [More Information]
  • Crawford, B., Labio, E., Strasser, S., McCaughan, G. (2006). Vitamin D replacement for cirrhosis-related bone disease. Nature Clinical Practice Gastroenterology and Hepatology, 3(12), 689-699. [More Information]

2005

  • Perry, J., Poustchi, H., George, J., Farrell, G., McCaughan, G., Strasser, S. (2005). Current approaches to the diagnosis and management of hepatocellular carcinoma. Clinical and Experimental Medicine, 5(1), 1-13. [More Information]
  • McCaughan, G., Koorey, D., Strasser, S. (2005). Liver transplantation for viral hepatitis. British Journal of Hospital Medicine, 66(1), 8-12. [More Information]

2004

  • Samuel, D., Riordan, S., Strasser, S., Kurtovic, J., Singh-Grewel, I., Koorey, D. (2004). Severe Autoimmune Hepatitis First Presenting In The Early Post Partum Period. Clinical Gastroenterology and Hepatology, 2(7), 622-624. [More Information]

2003

  • Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., McCaughan, G. (2003). Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplantation, 9(5), 500-505. [More Information]
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive Transfer of Nut Allergy After Liver Transplantation. Archives of Internal Medicine, 163(2), 237-239. [More Information]
  • Phan, T., Strasser, S., Koorey, D., McCaughan, G., Rimmer, J., Dunckley, H., Goddard, L., Adelstein, S. (2003). Passive transfer of nut allergy after liver transplantation. Archives of Internal Medicine, 163(2), 237-239. [More Information]
  • Perry, J., Strasser, S., George, J., Farrell, G., McCaughan, G. (2003). Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy, 4(12), 2175-2185. [More Information]

2002

  • McCaughan, G., Koorey, D., Strasser, S. (2002). Hepatocellular carcinoma: current approaches to diagnosis and management. Internal Medicine Journal, 32(8), 394-400. [More Information]
Back to Top

To update your profile click here. For support on your academic profile contact .